Evidence map›Paper›PMID 32512917›Full record

ArticleCancers2020

Interleukins 4 and 13 and Their Receptors Are Differently Expressed in Gastrointestinal Tract Cancers, Depending on the Anatomical Site and Disease Advancement, and Improve Colon Cancer Cell Viability and Motility.

Iwona Bednarz-Misa, Dorota Diakowska, Izabela Szczuka, Paulina Fortuna, Agnieszka Kubiak, Joanna Rosińczuk, Małgorzata Krzystek-Korpacka

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. IL-10 as a Th2 Cytokine: Differences Between Mice and Humans.Journal of immunology (Baltimore, Md. : 1950) · 2021
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Iwona Bednarz-MisaDepartment of Medical Biochemistry, Wroclaw Medical University, 50-368 Wroclaw, Poland.ORCID 0000-0001-7244-2017
Dorota DiakowskaDepartment of Gastrointestinal and General Surgery, Wroclaw Medical University, 50-368 Wroclaw, Poland.ORCID 0000-0002-1377-5601
Izabela SzczukaDepartment of Medical Biochemistry, Wroclaw Medical University, 50-368 Wroclaw, Poland.ORCID 0000-0001-7311-9633
Paulina FortunaDepartment of Medical Biochemistry, Wroclaw Medical University, 50-368 Wroclaw, Poland.ORCID 0000-0003-4617-798X
Agnieszka KubiakDepartment of Medical Biochemistry, Wroclaw Medical University, 50-368 Wroclaw, Poland.
Joanna RosińczukDepartment of Nervous System Diseases, Wroclaw Medical University, 51-618 Wroclaw, Poland.ORCID 0000-0001-7359-2287
Małgorzata Krzystek-KorpackaDepartment of Medical Biochemistry, Wroclaw Medical University, 50-368 Wroclaw, Poland.ORCID 0000-0002-2753-8092
Wroclaw Medical University · PL

Funding

Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu SUB.A040.19.016.
6 · The paper itself

Abstract

Immunosuppressive interleukins (IL)-4 and 13 may directly promote cancer but neither their status nor role in gastrointestinal tract is clarified. We aim at quantifying ILs and their receptors in paired normal-tumor samples (

Indexed as

colorectal canceresophageal squamous cell carcinomagastric adenocarcinomaimmunotherapyinterleukinmolecular margin

Identifiers

PMID32512917
PMCPMC7352212
OpenAlexW3033688257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.